Vedolizumab in PSC and concurrent IBD: Searching for the missing link between the gut and the liver, and exploration of biomarkers for development of colorectal carcinoma
Latest Information Update: 09 Jan 2018
At a glance
- Drugs Vedolizumab (Primary)
- Indications Cholangitis; Inflammatory bowel diseases; Ulcerative colitis
- Focus Biomarker; Pharmacodynamics
- Acronyms VIP
- 09 Jan 2018 New trial record